H970182 | 维生素A醋酸酯干粉 | retinyl acetate | Other | Chemical Drugs | Import Drug Application | 2000-01-01 | 罗氏(中国)投资有限公司北京办事处 | Roche(China)Holding Ltd Beijing | Approval Completed-Pending Certificated | | view |
JXSS2000011 | Satralizumab注射液 | satralizumab | Injection | Biological Products | Import Drug Application | 2020-05-15 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-14 | view |
JXSL1700083 | Gantenerumab注射液 | gantenerumab | Injection | Biological Products | Import Drug Application | 2017-12-04 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-08-27 | view |
JYSB1900336 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-01-22 | view |
JYSB1500428 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2015-12-24 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2016-04-11 | view |
JXHL1900176 | Idasanutlin片 | idasanutlin | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-07-31 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2019-07-30 | view |
JXSL1400017 | Gantenerumab 注射液 | gantenerumab | Injection | Biological Products | Import Drug Application | 2014-03-27 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-12-24 | view |
JYSB2000694 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JXSL2000085 | Gantenerumab注射液 | gantenerumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-07-02 | view |
JYSB1900081 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2019-04-11 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-12-13 | view |
JXHB2000053 | GDC-0077 | inavolisib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2020-11-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-11-21 | view |
JYSB2000195 | Gantenerumab注射液 | gantenerumab | Injection | Biological Products | Supplementary Application | 2020-05-27 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-26 | view |
JYSB1800185 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2018-08-30 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-12-19 | view |
JXHL2000013 | Idasanutlin片 | idasanutlin | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-02-15 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-02-14 | view |
JYHB1601018 | 马来酸咪达唑仑片 | midazolam maleate | Tablet | Chemical Drugs | Supplementary Application | 2016-08-05 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2017-04-18 | view |
JYHZ1900224 | 马来酸咪达唑仑片 | midazolam maleate | Tablet | Chemical Drugs | License Renew | 2019-08-17 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-12-20 | view |
JYHB1400897 | 甲磺酸沙奎那韦胶囊 | saquinavir mesylate | Capsule | Chemical Drugs | Supplementary Application | 2014-07-04 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2016-02-15 | view |
JXSS2100023 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-04-07 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-11-19 | view |
JXSL2000119 | Gantenerumab注射液 | gantenerumab | Injection | Biological Products | Import Drug Application | 2020-07-08 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-07-07 | view |
JXSL1900051 | 注射用 Polatuzumab vedotin | polatuzumab vedotin | Lyophilized | Biological Products | Import Drug Application | 2019-05-20 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2019-05-17 | view |